Standout Papers
Citation Impact
Citing Papers
The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease
2009
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Implementing shared treatment decision making and treatment decision aids: a cautionary tale
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
2010
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Location of Acute Myocardial Infarction and Associated Arrhythmias and Outcome
2009
Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction
2006
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study
2005
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services
2010
Intra‐Aortic Balloon Counterpulsation in the Treatment of Infarction‐Related Cardiogenic Shock—Review of the Current Evidence
2012
Long-term follow-up of patients treated with coronary angioplasty for acute myocardial infarction
1989
The cost-effectiveness of patient decision aids: A systematic review
2014
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
2009
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Prospects for Cardiovascular Research
2001 StandoutNobel
Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy
1990
Omeprazole and clopidogrel: Should clinicians be worried?
2010
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double-blind, placebo-controlled study
1998
The Myth of the “Vulnerable Plaque”
2015
Shared Decision Making Guidance Reminders in Practice (SDM-GRIP)
2011
Shared Decision Making in Patients with Stable Coronary Artery Disease: PCI Choice
2012
A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock
2006
New Antithrombotic Drugs
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
2005
Clopidogrel Increases Blood Transfusion and Hemorrhagic Complications in Patients Undergoing Cardiac Surgery
2010
The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: Study rationale and design
2007
Decision aids for people facing health treatment or screening decisions
2011
Decision aids for patients facing health treatment or screening decisions: systematic review
1999
A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor
1999
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy
1997
Decision aids for people facing health treatment or screening decisions
2014
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
2009
Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
2014
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Impact of P-glycoprotein on clopidogrel absorption
2006
From myocardial salvage to patient salvage in acute myocardial infarction: The role of reperfusion therapy
1989
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction
2003
A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
2008
Decision aids for people facing health treatment or screening decisions
2003
Effects of Decision Aids for Menorrhagia on Treatment Choices, Health Outcomes, and Costs
2002
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Intra-Aortic Balloon Counterpulsation
2006
Cardiac imaging after myocardial infarction
2010
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Where is the theory? Evaluating the theoretical frameworks described in decision support technologies
2008
Intra-aortic Balloon Counterpulsation and Infarct Size in Patients With Acute Anterior Myocardial Infarction Without Shock
2011
Antithrombotic Therapy for VTE Disease
2012 Standout
Increasing Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction in the United States
2014
Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy
2009
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: Results from TIMI II
1992
Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction
1989
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
2008
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment
2006
Decision aids for people facing health treatment or screening decisions
2009
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction
2006
Cardiogenic shock complicating acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events
2012
Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction
1993
Antiplatelet Drugs
2008
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
Parenteral inotropic support for advancedcongestive heart failure
1998
Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial
2007
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
2015
Potential survival gains in the treatment of myocardial infarction
2009
Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials
2011
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology
2013
Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction
1990
Cell-Penetrating Peptides: From Basic Research to Clinics
2017
Decision Aids for Patients Considering Options Affecting Cancer Outcomes: Evidence of Efficacy and Policy Implications
1999
A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy
2002
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
2008
Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial
2005
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)
2003
Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis
2007
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study
1998
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE Multicenter Trial
1999
Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester heart attack study)
1992
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Diagnosis of ST-Elevation Myocardial Infarction in the Presence of Left Bundle Branch Block With the ST-Elevation to S-Wave Ratio in a Modified Sgarbossa Rule
2012
Time to Treatment in Primary Percutaneous Coronary Intervention
2007
Atherosclerosis — An Inflammatory Disease
1999 Standout
Cardiac syndrome X: Clinical characteristics and left ventricular function
1995
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
2010
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
2009
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
2008
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
2006
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
2009
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD
2012
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
1999
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
2009
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention
2008
Intravenous Amiodarone for Acute Heart Rate Control in the Critically Ill Patient With Atrial Tachyarrhythmias
1998
Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversies
1990
Adenosine
2014
Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)
2006
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
2013
Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: Results from the American College of Cardiology’s NCDR®
2011
Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart
2002
System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention
2010
Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization
2013
Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction
1990
SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/CABG—trial design
1999
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Interpretive Review : Feasibility and Effects of Decision Aids
2000
Antithrombotic Therapy During Percutaneous Coronary Intervention
2004
Women and Ischemic Heart Disease
2009
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
2012
Degree of Anticoagulation after One Subcutaneous and One Subsequent Intravenous Booster Dose of Enoxaparin: Implications for Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention
2004
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
2005
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)
2007
Assessment of acute myocardial infarction: current status and recommendations from the North American society for cardiovascular imaging and the European society of cardiac radiology
2010
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
2011
Effect of age on outcome with primary angioplasty versus thrombolysis
1999
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation
2000
Platelet-Active Drugs
2001
“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries
1988 Standout
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial
2009
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease
2000
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
2010
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With Enoxaparin
2004
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes
2004
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiplatelet Therapy and Proton Pump Inhibition
2012
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1987
Cardiogenic Shock
1999
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Antithrombotic Therapy in Patients With Chronic Kidney Disease
2012
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
Early and Delayed Consequences of β 2 -Adrenergic Receptor Overexpression in Mouse Hearts
2000
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 Standout
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
2004
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel
2009
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Patients or Volunteers? The Impact of Motivation for Trial Participation on the Efficacy of Patient Decision Aids: A Secondary Analysis of a Cochrane Systematic Review
2015
Guidelines for percutaneous transluminal coronary angioplasty
1988
Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention
2016
Patient Decision Aids to Support Clinical Decision Making: Evaluating the Decision or the Outcomes of the Decision
2007
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors
1995
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
2009
Decision aids for people facing health treatment or screening decisions
2017 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services
2010
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Adaptation and Maladaptation of the Heart in Diabetes: Part I
2002
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
CXC chemokines in angiogenesis
2000
Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention
2013
Impact of an Educational Video on Patient Decision Making in Early Breast Cancer Treatment
2006
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents
2015
Oxygen therapy for acute myocardial infarction
2016
Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy
2004
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
2000
Long-Term Mortality Data From the Balloon Pump–Assisted Coronary Intervention Study (BCIS-1)
2012
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
1988
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Effects of Atrial Natriuretic Factor on the Kidney and the Renin-Angiotensin-Aldosterone System
1987
The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey
2014
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Low- and high-level transgenic expression of β 2 -adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice
1999
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY
1987
Adaptation and Maladaptation of the Heart in Diabetes: Part II
2002
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock
2003
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
2008
Fourth universal definition of myocardial infarction (2018)
2018 Standout
A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
2007
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
2013
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients
1987
TIMI Frame Count
1996 Standout
The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
2003 StandoutNobel
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
1988 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey
2014
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Coronary Thrombolysis for the Elderly?
1991
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
2013
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Eric Bates being referenced
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States
2006
Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy
1993
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age
1989
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Assessing the Current Role of Platelet Function Testing
2008
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy
2010
Time to Treatment in Patients with STEMI
2013
Predictors of length of stay after coronary stenting
2001
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy
1991
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
2000
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
2011
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
2000
A randomized controlled trial of information‐giving to patients referred for coronary angiography: effects on outcomes of care
1998
Baseline Coronary Angiographic Findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D)
2009
Predictors of success for coronary angioplasty performed for acute myocardial infarction
1988
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability
2002
Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction
1989
Prospects for the use of antagonists to the platelet glycoprotein IIb/ IIIa receptor to prevent postangioplasty restenosis and thrombosis
1991
Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Does the choice of fibrinolytic agent impact on the importance of time-to-treatment?
2004
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality
1989
Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
2014
Acute ST-elevation myocardial infarction
2012
Reperfusion therapy in inferior myocardial infarction
1988
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: Development of a predictive model
1997
Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock
1991
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set
1999
Prognostic implication of troponin I elevation after percutaneous coronary intervention
2003
An analysis of the cause of early mortality after administration of thrombolytic therapy
1993
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study
2003
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?
2003
Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction
2002
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure
1986
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
2008
IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue
2000
Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms
1985
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
2016
Emergency Department Bypass for ST-Segment–Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram
2013
The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.
1986
Application of digital techniques to selective coronary arteriography: Use of myocardial contrast appearance time to measure coronary flow reserve
1984
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
2016
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
2003
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction
1986
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock.
1988
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.
1987
Cardiogenic Shock
1995
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization
1985
Treatment Strategies for Acute Myocardial Infarction Complicated by Cardiogenic Shock in a Community Hospital
1994
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
2011
False activation of the cardiac catheterization laboratory for primary PCI.
2013
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction
2006
Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
2009
Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States
2005
Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
2008